Shimira Pharma Private Limited
About Shimira Pharma Private Limited
Data last updated:
Shimira Pharma Private Limited is a private limited company based in Bhopal, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 July 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24239MP2021PTC056775.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Srivastava Neera and Pramod Srivastava.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 504 Block – B Shiv Angan Complex Sallaiya, Bhopal, Madhya Pradesh, India – 462026.
Company details
Contact details
Shimira Pharma Private Limited's registered office is in Bhopal, Madhya Pradesh.
- Registered Address504 Block – B Shiv Angan Complex Sallaiya, Bhopal, Madhya Pradesh, India – 462026
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Shimira Pharma Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ||||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ||||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | ||||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Shimira Pharma Private Limited, buy the company report.
Board of directors of Shimira Pharma Private Limited
Shimira Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srivastava Neera | Director | 21 Jul 2021 | 5 Years 3 Months | Current |
| Pramod Srivastava Also directs: Jivdhara Pharma Private Limited | Director | 21 Jul 2021 | 5 Years 3 Months | Current |
Legal cases
No court or tribunal cases involving Shimira Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Shimira Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Shimira Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Shimira Pharma Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Pramod Srivastava was appointed as Director on 21 Jul 2021.
Frequently asked questions
Shimira Pharma is an active private limited company based in Bhopal, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 July 2021 (5+ years old) and is registered under CIN U24239MP2021PTC056775.
Shimira Pharma has 2 current directors:
- Srivastava Neera - Director
- Pramod Srivastava - Director
The latest financial statements of Shimira Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Shimira Pharma is U24239MP2021PTC056775. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Shimira Pharma was incorporated on 21 July 2021, making it 5+ years old. It is registered with the Registrar of Companies, Gwalior.
Pramod Srivastava was appointed as Director on 21 Jul 2021. Srivastava Neera was appointed as Director on 21 Jul 2021.
The registered office of Shimira Pharma is at 504 Block – B Shiv Angan Complex Sallaiya, Bhopal, Madhya Pradesh, India – 462026.
Shimira Pharma operates in the pharma industry, in the drug formulation and development segment.
Shimira Pharma can be reached at its registered office: 504 Block – B Shiv Angan Complex Sallaiya, Bhopal, Madhya Pradesh, India – 462026.
Shimira Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Gwalior.